MetLife Investment Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Buy |
45,525
+69
| +0.2% | +$248 | ﹤0.01% | 2287 |
|
|
2025
Q1 | $136K | Buy |
45,456
+8,365
| +23% | +$25K | ﹤0.01% | 2385 |
|
|
2024
Q4 | $124K | Sell |
37,091
-8,109
| -18% | -$27.2K | ﹤0.01% | 2524 |
|
|
2024
Q3 | $151K | Hold |
45,200
| – | – | ﹤0.01% | 2433 |
|
|
2024
Q2 | $150K | Buy |
45,200
+7,475
| +20% | +$24.7K | ﹤0.01% | 2413 |
|
|
2024
Q1 | $152K | Sell |
37,725
-9,509
| -20% | -$38.4K | ﹤0.01% | 2336 |
|
|
2023
Q4 | $144K | Hold |
47,234
| – | – | ﹤0.01% | 2415 |
|
|
2023
Q3 | $142K | Hold |
47,234
| – | – | ﹤0.01% | 2398 |
|
|
2023
Q2 | $177K | Hold |
47,234
| – | – | ﹤0.01% | 2354 |
|
|
2023
Q1 | $158K | Hold |
47,234
| – | – | ﹤0.01% | 2357 |
|
|
2022
Q4 | $227K | Hold |
47,234
| – | – | ﹤0.01% | 2172 |
|
|
2022
Q3 | $269K | Buy |
47,234
+8,168
| +21% | +$46.5K | ﹤0.01% | 2099 |
|
|
2022
Q2 | $277K | Hold |
39,066
| – | – | ﹤0.01% | 2074 |
|
|
2022
Q1 | $282K | Buy |
39,066
+14,418
| +58% | +$104K | ﹤0.01% | 2128 |
|
|
2021
Q4 | $220K | Hold |
24,648
| – | – | ﹤0.01% | 1992 |
|
|
2021
Q3 | $864K | Hold |
24,648
| – | – | 0.01% | 1196 |
|
|
2021
Q2 | $529K | Buy |
24,648
+19,099
| +344% | +$410K | ﹤0.01% | 1537 |
|
|
2021
Q1 | $343K | Sell |
5,549
-1,387
| -20% | -$85.6K | ﹤0.01% | 1740 |
|
|
2020
Q4 | $290K | Buy |
+6,936
| New | +$290K | ﹤0.01% | 1785 |
|